MYDA Advisors’s CARGO Therapeutics CRGX Stock Holding History

MYDA Advisors’s Portfolio CRGX Stock Details CRGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-30,000	Closed	-$122K	–	154
2025 Q1	$122K	Buy	+30,000	New	+$201K	0.02%	138

Other funds holding CRGX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TGV

TRV GP VI Boston, Massachusetts $136M AUM 328.39% 1-Year Est. Return

TGV

TRV GP V Boston, Massachusetts $401M AUM 284.76% 1-Year Est. Return

MYDA Advisors's CRGX Position: Q2 2025 in Review

MYDA Advisors sold out of CARGO Therapeutics (CRGX) in Q2 2025, closing a stake of 30,000 shares — an estimated $122K sold.

MYDA Advisors first reported a position in CRGX in Q1 2025 and held it in 1 quarter. The position peaked at $122K in Q1 2025. 116 funds tracked by Wall St. Rank hold CRGX as of Q2 2025.

MYDA Advisors reported no remaining CARGO Therapeutics position as of Q2 2025 after selling out during the quarter.
MYDA Advisors sold 30,000 CARGO Therapeutics shares in Q2 2025, an estimated $122K.
MYDA Advisors first reported a position in CARGO Therapeutics in Q1 2025 and held it in 1 quarter.
MYDA Advisors's CARGO Therapeutics position peaked at $122K in Q1 2025.
116 funds tracked by Wall St. Rank held CARGO Therapeutics as of Q2 2025.

Based on MYDA Advisors's 13F filing for Q2 2025, filed 13 Aug 2025.